What is Imatinib Mesylate?

Imatinib Mesylate is a chemical product listing on XCHEMI (https://www.xchemi.com), offered by FRESENIUS-KABI ONCOLOGY LTD for international B2B procurement. The CAS Registry Number shown on this listing is 220127-57-1. Specifications on this page are provided by the supplier; confirm critical attributes before purchase.

What is the CAS number for this listing?

This XCHEMI product page lists CAS 220127-57-1 for Imatinib Mesylate. CAS numbers help align chemical identity across suppliers and regions. Always verify identity, grade, and impurity profile with supplier documentation (e.g., COA) before use in regulated processes.

How can I request a quotation or buy Imatinib Mesylate?

Use the XCHEMI marketplace actions on this listing (https://www.xchemi.com/product/861324908560787122.html) to contact FRESENIUS-KABI ONCOLOGY LTD and request a quotation (RFQ). Offer price and currency—when shown—come from the supplier listing and may vary by quantity and shipping terms.

How should chemicals be stored and handled?

Follow supplier SDS / label instructions, local regulations, and your site safety program. XCHEMI is a B2B marketplace; obtain current SDS and handling guidance from FRESENIUS-KABI ONCOLOGY LTD before receipt, storage, or use.

What are typical applications for Imatinib Mesylate?

Applications depend on industry segment and process requirements. Use this listing as a sourcing lead and validate fitness-for-purpose with FRESENIUS-KABI ONCOLOGY LTD for your intended use (e.g., synthesis, formulation, manufacturing).

Is a safety data sheet (SDS / MSDS) available?

Request SDS/MSDS and regulatory documents from FRESENIUS-KABI ONCOLOGY LTD through XCHEMI quotation or supplier contact. Marketplace summaries do not replace official safety documentation.

Who is the seller for this product on XCHEMI?

FRESENIUS-KABI ONCOLOGY LTD is identified as the seller on this listing. You can open the supplier storefront from this page when available to review company profile and other listed chemicals.